SPHERA FUNDS MANAGEMENT LTD.

Position in BIOA — BioAge Labs, Inc.

CIK 1496201 TEL AVIV, L3

Position in BIOA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,237,076

+$3,723,877 QoQ

Shares Held

213,671

+147.0% QoQ

Ownership

0.466%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

#39

of 151 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $61,616,864 across 4 Drug Manufacturers - Specialty & Generic names. BIOA ranks #2 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	1,500,082	$50,822,778
2	BIOA	BioAge Labs, Inc. This page	213,671	$5,237,076
3	BCRX	Biocryst Pharmaceuticals Inc	422,051	$4,220,510
4	ORGO	Organogenesis Holdings Inc.	550,000	$1,336,500

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,237,076	213,671	+147.0%	Shares	Defined	2026-08-14
2026-03-31	$1,513,199	86,518	-64.4%	Shares	Defined	2026-05-15
2025-12-31	$3,215,353	243,035	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.